Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-21

Clinical Trial Update: Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial comparing BOL-303259-X ophthalmic solution to Timolol for open-angle glaucoma or ocular hypertension completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BOL-303259-X
  • Timolol maleate (Timolol maleate)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Open-Angle Glaucoma, Ocular Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2018-11-21